Menu

Mitochondrial Activity Predicts Fish Life Span?

Scientists identify an inverse relationship between longevity in killifish and the expression of genes related to cellular respiration.

Feb 25, 2016
Catherine Offord

N. rachovii, a related speciesWIKIMEDIA, ANDREAS WRETSTROMThe activity of mitochondria decreases as humans get older—a trend thought to be related to worsening health. But in African turquoise killifish (Nothobranchius furzeri), the world’s shortest-lived vertebrate, there appears to be an inverse relationship between the early-life expression of genes involved in mitochondrial function and average life span, according to a study published yesterday (February 24) in Cell Systems.

The researchers analyzed gene expression in fin tissue collected from 152 male killifish at various times in their 12-month lives. They found that young fish with low expression of genes involved in respiration lived longer than those who’d exhibited high expression early in life. What’s more, exposing the fish to small doses of rotenone, a natural poison that inhibits mitochondrial function, extended life span in the fish by about 15 percent.

“Up to the present, it was thought that improving mitochondrial function would improve health in aged people,” study coauthor Alessandro Cellerino of the Scuola Normale Superiore in Pisa, Italy, and the Leibniz Institute on Aging in Jena, Germany, said in a statement. “However, our results indicate a more complex scenario, where the partial inhibition of mitochondrial function paradoxically has beneficial effects.”

One explanation for the relationship could be that inhibiting mitochondrial function produces free radicals that, in low quantities, can stimulate a positive, adaptive response to stress known as hormesis, the authors suggested. “It was recently demonstrated that the positive effects of physical exercise in humans are due to hormesis, and are destroyed by treatment with antioxidants,” explained Cellerino in the statement. He added that although the link has yet to be tested in humans, the team’s finding has “implications on the development of strategies to improve health in older people and prevent aging-associated diseases.”

“This study supports the hypothesis that mitochondria, the batteries of the cells, are determinants in the aging process,” Joao Passos of Newcastle University Institute for Ageing in the U.K. who was not involved in the study told New Scientist. “This and other studies offer us clues about potential interventions to ameliorate the aging process.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.